Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy

被引：0
|
作者：
Ismail Sari
Omer Binicier
Merih Birlik
Servet Akar
Erkan Yilmaz
Aydanur Kargi
Fatos Onen
Nurullah Akkoc
机构：
[1] Dokuz Eylul University School of Medicine,Department of Internal Medicine, Division of Rheumatology
[2] Dokuz Eylul University School of Medicine,Department of Radiology
[3] Dokuz Eylul University School of Medicine,Department of Pathology
[4] Dokuz Eylul Universitesi Tip Fakultesi Ic hastaliklari ABD Immunoloji-Romatoloji,undefined
来源：
Rheumatology International | 2009年 / 29卷
关键词：
Tumor necrosis factor alpha inhibitors; Adverse effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumor necrosis factor (TNF) alpha inhibitors are effective in the treatment of inflammatory rheumatic diseases. Despite their effectiveness, anti-TNF drugs have some drawbacks such as severe adverse effects including infections and possibly lymphoproliferative disorders. In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment. The clinical presentation was highly suggestive of malignancy and the patient underwent diagnostic mediastinoscopy with biopsy.
引用
收藏
相关论文
共 50 条
  • [1] Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy
    Sari, Ismail
    Binicier, Omer
    Birlik, Merih
    Akar, Servet
    Yilmaz, Erkan
    Kargi, Aydanur
    Onen, Fatos
    Akkoc, Nurullah
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (05) : 591 - 593
  • [2] Etanercept therapy in juvenile idiopathic arthritis
    Nature Reviews Rheumatology, 2012, 8 (2) : 62 - 62
  • [3] AKI in a Patient on Etanercept for Juvenile Idiopathic Arthritis
    Al-Sammarraie, Riyam
    Segamwenge, Innocent
    Robertson, Stuart
    KIDNEY360, 2024, 5 (02): : 327 - 328
  • [4] Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis
    A. Holl-Wieden
    M. Beer
    A. Marx
    R. Bonfig
    D. Tappe
    H. J. Girschick
    Rheumatology International, 2008, 28 : 819 - 822
  • [5] Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis
    Holl-Wieden, A.
    Beer, M.
    Marx, A.
    Bonwg, R.
    Tappe, D.
    Girschick, H. J.
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (08) : 819 - 822
  • [6] Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
    Arina Lazareva
    Valda Stanevicha
    Jelizaveta Semjonova
    Ruta Shantere
    Inita Buliņa
    Pediatric Rheumatology, 9 (Suppl 1)
  • [7] Etanercept and leflunomide combination therapy in juvenile idiopathic arthritis (JIA)
    Horneff, G.
    Moebius, B.
    Michels, H.
    Foldvari, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 439 - 440
  • [8] Etanercept shown to be an effective therapy for juvenile idiopathic arthritis sufferers
    Wilkinson, Jonathan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (01) : 22 - 22
  • [9] Etanercept in systemic juvenile idiopathic arthritis
    Russo, RAG
    Katsicas, MM
    Zelazko, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (05) : 723 - 726
  • [10] Combination therapy with etanercept and methotrexate compared to etanercept monotherapy in patients with juvenile idiopathic arthritis
    Horneff, G
    Girschick, H
    Foeldvari, I
    Michels, H
    Rogalski, B
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S724 - S725
12345